4928 related articles for article (PubMed ID: 4549213)
41. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
Saal JG; Rieber EP; Riethmüller G
Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
[TBL] [Abstract][Full Text] [Related]
42. Reaction of human lymphocytes with aggregated IgG columns. Effect on antibody-dependent cytotoxicity and EAC rosette formation.
Isturiz MA; de Bracco MM; Manni JA
Cell Immunol; 1975 Mar; 16(1):82-91. PubMed ID: 1167813
[No Abstract] [Full Text] [Related]
43. Early onset of serum blocking in a murine melanoma model.
Bray AE; Holt PG; Roberts LM; Keast D
Int J Cancer; 1975 Oct; 16(4):607-15. PubMed ID: 1176208
[TBL] [Abstract][Full Text] [Related]
44. Letter: Rosette formation, phytohaemagglutinin, and autoreactivity.
Blecher SR
Lancet; 1974 Apr; 1(7860):748-9. PubMed ID: 4132483
[No Abstract] [Full Text] [Related]
45. Immune response to a transplantable malignant melanoma in mice.
Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
[No Abstract] [Full Text] [Related]
46. Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity.
Galili U; Schlesinger M
J Immunol; 1975 Sep; 115(3):827-33. PubMed ID: 125304
[TBL] [Abstract][Full Text] [Related]
47. Cell-mediated and humoral immune reactions to human tumours.
Baldwin RW; Embleton MJ; Jones JS; Langman MJ
Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
[No Abstract] [Full Text] [Related]
48. Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses.
Cassel WA; Murray DR; Torbin AH; Olkowski ZL; Moore ME
Cancer; 1977 Aug; 40(2):672-9. PubMed ID: 196739
[TBL] [Abstract][Full Text] [Related]
49. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
[No Abstract] [Full Text] [Related]
50. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
51. Marine invertebrate origin of a reactant to mammalian T cells.
Prendergast RA; Cole GA; Henney CS
Ann N Y Acad Sci; 1974; 234(0):7-17. PubMed ID: 4153401
[No Abstract] [Full Text] [Related]
52. Thymus-derived lymphocytes in patients with solid malignancies.
Potvin C; Tarpley JL; Chretien B
Clin Immunol Immunopathol; 1975 Mar; 3(4):476-81. PubMed ID: 1078796
[No Abstract] [Full Text] [Related]
53. The role of humoral factors in the initiation of in vitro primary immune responses. IV. Are macrophages the adherent cell type required for cell cooperation.
Watson J; Thoman M; Ralph P; Trenkner E
J Immunol; 1974 May; 112(5):1873-83. PubMed ID: 4131877
[No Abstract] [Full Text] [Related]
54. Identification of subpopulations of mononuclear cells in cutaneous infiltrates. I. Differentiation between B cells, T cells, and histiocytes.
Edelson RL; Smith RW; Frank MM; Green I
J Invest Dermatol; 1973 Aug; 61(2):82-9. PubMed ID: 4542256
[No Abstract] [Full Text] [Related]
55. Cell-mediated cytotoxic reactions to tumor associated antigens.
Herberman RB
J Reticuloendothel Soc; 1975 Apr; 17(4):236-40. PubMed ID: 50447
[No Abstract] [Full Text] [Related]
56. Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells.
Hersey P; Edwards J; Edwards A; Adams E; Kearney R; Milton GW
Int J Cancer; 1975 Jul; 16(1):164-72. PubMed ID: 1080748
[TBL] [Abstract][Full Text] [Related]
57. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
[No Abstract] [Full Text] [Related]
58. Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers.
Pattengale PK; Smith RW; Perlin E
N Engl J Med; 1974 Nov; 291(22):1145-8. PubMed ID: 4138509
[No Abstract] [Full Text] [Related]
59. In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers.
Mellstedt H; Jondal M; Holm G
Clin Exp Immunol; 1973 Nov; 15(3):321-30. PubMed ID: 4543556
[TBL] [Abstract][Full Text] [Related]
60. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
